Synapse - Works

Results (2639)

PD-1 blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: Results from a multicenter cohort

Meeting Abstract

Desai, S. H.; Merryman, R. W.; Shah, H.; Pederson, L. D.; Geyer, S. M.; Ganesan, N.; Chang, T.; Othman, T.; Falade, A. S.; Shah, G. L.; more...
Blood (2023)

Fulltext@MSK | Save

Patient-reported outcomes from the MCL cohort of the phase 1, seamless design TRANSCEND NHL 001 study of lisocabtagene maraleucel in patients with R/R B-cell NHL

Meeting Abstract

Wang, M. L.; Gordon, L. I.; Hirayama, A. V.; Lunning, M. A.; Shi, L.; Guo, S.; Kostic, A.; Eliason, L.; Kumar, J.; Palomba, M. L.
Blood (2023)

Fulltext@MSK | Save

Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability

Meeting Abstract

Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
Blood (2023)

Fulltext@MSK | Save

Quality of life and global response score in cutaneous T-cell lymphoma

Meeting Abstract

Khan, N.; Drill, E.; Moskowitz, A.; Shinohara, M. M.; Larocca, C.; Querfeld, C.; Zain, J. M.; Horwitz, S. M.
Blood (2023)

Fulltext@MSK | Save

Outcomes in mantle cell lymphoma with central nervous system involvement - A dual center study

Meeting Abstract

McLaughlin, N.; Joseph, A.; Wang, Y. C.; Pederson, L. D.; Geyer, S. M.; Witzig, T. E.; Zelenetz, A. D.; Villasboas, J. C. C.; Scordo, M.; Hamlin, P. A.; more...
Blood (2023)

Fulltext@MSK | Save

A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma

Meeting Abstract

Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
Blood (2023)

Fulltext@MSK | Save

Subcutaneous (SC) mosunetuzumab (mosun) as first-line therapy for patients (pts) with high tumor-burden follicular lymphoma (FL): First results of a multicenter phase 2 study

Meeting Abstract

Falchi, L.; Okwali, M.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Palomba, M. L.; Kumar, A.; Torka, P.; more...
Blood (2023)

Fulltext@MSK | Save

Polytypic B-cells, B-cell lymphoproliferative disorders/lymphomas, and neoplastic T-cells divergently differentiate from TET2-/ DNMT3A-mutated clonal hematopoiesis in patients with follicular helper T-cell lymphomas/lymphoproliferative disorders

Meeting Abstract

Lewis, N.; Petrova-Drus, K.; Sardana, R.; Gao, Q.; Sethi, S.; Xiao, W.; Roshal, M.; Baik, J.; Bhurtel, H.; Moskowitz, A.; more...
Blood (2023)

Fulltext@MSK | Save

A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2

Meeting Abstract

Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
Blood (2023)

Fulltext@MSK | Save

Ruxolitinib promotes clinical responses in large granular lymphocytic leukemia via suppression of JAK/STAT-dependent inflammatory cascades

Meeting Abstract

Moskowitz, A.; Rahman, J.; Ganesan, N.; Hannigan, K.; Ksanznak, K.; Bitton, H.; Lin, Y. H.; Davey, T.; Hancock, H.; Perez, L.; more...
Blood (2023)

Fulltext@MSK | Save